Cedar Pollinosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy (NCT02469688) | Astellas Pharma Inc | 2015-06-18 |
Track Cedar Pollinosis automatically
Every clearance here is in the API, with alerts when new ones post.